3/29
04:12 pm
roiv
Is Roivant Sciences (ROIV) the Best Mid Cap Biotech Stock to Buy? [Yahoo! Finance]
Low
Report
Is Roivant Sciences (ROIV) the Best Mid Cap Biotech Stock to Buy? [Yahoo! Finance]
3/19
07:45 am
roiv
Roivant Announces Positive Results for Batoclimab Myasthenia Gravis (MG) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Studies
Low
Report
Roivant Announces Positive Results for Batoclimab Myasthenia Gravis (MG) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Studies
3/18
04:32 pm
roiv
Roivant to Host Investor Webcast at 8:00 AM ET on Wednesday, March 19 to Review Results from Batoclimab Myasthenia Gravis (MG) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Programs
Low
Report
Roivant to Host Investor Webcast at 8:00 AM ET on Wednesday, March 19 to Review Results from Batoclimab Myasthenia Gravis (MG) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Programs
3/5
07:43 am
roiv
Roivant Sciences Ltd. (NASDAQ: ROIV) was upgraded by analysts at Cantor Fitzgerald to a "strong-buy" rating.
Medium
Report
Roivant Sciences Ltd. (NASDAQ: ROIV) was upgraded by analysts at Cantor Fitzgerald to a "strong-buy" rating.
3/3
09:53 am
roiv
Genevant Sciences and Arbutus Biopharma Initiate International Patent Infringement Enforcement Actions Against Moderna [Yahoo! Finance]
Low
Report
Genevant Sciences and Arbutus Biopharma Initiate International Patent Infringement Enforcement Actions Against Moderna [Yahoo! Finance]
2/25
08:00 am
roiv
Early Warning Report Issued Pursuant to National Instrument 62-103: Roivant announces Resignation and Replacement of Arbutus Board
Medium
Report
Early Warning Report Issued Pursuant to National Instrument 62-103: Roivant announces Resignation and Replacement of Arbutus Board
2/20
03:12 pm
roiv
Will Moderna Stock Drop to $25? 1 Wall Street Analyst Thinks So. [Yahoo! Finance]
Low
Report
Will Moderna Stock Drop to $25? 1 Wall Street Analyst Thinks So. [Yahoo! Finance]
2/18
03:23 am
roiv
Vivek Ramaswamy to launch run for Ohio governor next week [USA TODAY]
Low
Report
Vivek Ramaswamy to launch run for Ohio governor next week [USA TODAY]
2/13
05:38 pm
roiv
Roivant Sciences price target lowered to $12 from $13 at BofA [Yahoo! Finance]
Low
Report
Roivant Sciences price target lowered to $12 from $13 at BofA [Yahoo! Finance]
2/11
12:29 pm
roiv
Roivant Sciences Ltd. (NASDAQ: ROIV) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $18.00 price target on the stock.
Low
Report
Roivant Sciences Ltd. (NASDAQ: ROIV) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $18.00 price target on the stock.
2/11
02:45 am
roiv
Roivant Sciences Ltd (ROIV) Q3 2024 Earnings Call Highlights: Strategic Moves and Financial ... [Yahoo! Finance]
Medium
Report
Roivant Sciences Ltd (ROIV) Q3 2024 Earnings Call Highlights: Strategic Moves and Financial ... [Yahoo! Finance]
2/11
12:04 am
roiv
Is Invesco S&P MidCap 400 Pure Growth ETF (RFG) a Strong ETF Right Now? [Yahoo! Finance]
Medium
Report
Is Invesco S&P MidCap 400 Pure Growth ETF (RFG) a Strong ETF Right Now? [Yahoo! Finance]
2/10
12:42 pm
roiv
Roivant Sciences Ltd. 2024 Q3 - Results - Earnings Call Presentation [Seeking Alpha]
Low
Report
Roivant Sciences Ltd. 2024 Q3 - Results - Earnings Call Presentation [Seeking Alpha]
2/10
07:37 am
roiv
Roivant Reports Financial Results for the Third Quarter Ended December 31, 2024, and Provides Business Update [Yahoo! Finance]
Medium
Report
Roivant Reports Financial Results for the Third Quarter Ended December 31, 2024, and Provides Business Update [Yahoo! Finance]
2/10
07:00 am
roiv
Roivant Reports Financial Results for the Third Quarter Ended December 31, 2024, and Provides Business Update
Low
Report
Roivant Reports Financial Results for the Third Quarter Ended December 31, 2024, and Provides Business Update
2/3
07:00 am
roiv
Zest Health Announces $13M in Funding to Curb Unnecessary Pharmaceutical Spend through High-Touch Care
Low
Report
Zest Health Announces $13M in Funding to Curb Unnecessary Pharmaceutical Spend through High-Touch Care
2/1
05:59 am
roiv
Roivant Sciences Ltd. (NASDAQ: ROIV) was upgraded by analysts at Cantor Fitzgerald to a "strong-buy" rating.
Medium
Report
Roivant Sciences Ltd. (NASDAQ: ROIV) was upgraded by analysts at Cantor Fitzgerald to a "strong-buy" rating.
1/29
04:05 pm
roiv
Roivant to Report Financial Results for the Third Quarter Ended December 31, 2024 and Provide Business Update on Monday, February 10, 2025
Low
Report
Roivant to Report Financial Results for the Third Quarter Ended December 31, 2024 and Provide Business Update on Monday, February 10, 2025
1/17
04:26 pm
roiv
Billionaire Vivek Ramaswamy Plans Ohio Governor Run [Forbes]
Low
Report
Billionaire Vivek Ramaswamy Plans Ohio Governor Run [Forbes]